Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 4 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 2OTHER_GOV 1NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Neoplasms 2Uterine Cervical Neoplasms 1Radiation Injuries 1Pelvic Inflammatory Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiovascular Diseases 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Antioxidants × Clear all
NCT03994055 2025-05-25

Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer

National Institute of Cancerología

Phase NA Completed
136 enrolled
Gynecologic

Pelvic Inflammatory Disease, Uterine Cervical Neoplasms, Neoplasms, Radiation Injuries

NCT02231203 2018-07-31

EMPIRE

Medical Center Alkmaar

Phase 4 Completed
44 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00046306 2013-01-14

Nevada Environmental Tobacco Smoke and Health Study

National Institute of Environmental Health Sciences (NIEHS)

Phase 3 Completed
375 enrolled

Cardiovascular Diseases, Neoplasms

NCT01437826 2011-09-21

Antioxidant Supplement and Reduction of Metachronous Adenomas of the Large Bowel: a Double Blind Randomized Trial

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

Phase 3 Terminated
411 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡